In a patient with a positive urine culture showing two organisms, one fully sensitive to nitrofurantoin (Macrobid) and the other intermediate, should the antibiotic dose be changed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Should the Antibiotic Be Changed?

No, continue nitrofurantoin (Macrobid) at standard dosing (100 mg twice daily for 5 days) if this is uncomplicated cystitis, but verify that the "intermediate" organism is not intrinsically resistant to nitrofurantoin (e.g., Proteus, Serratia, or Pseudomonas). 1, 2, 3

Key Decision Points

1. Verify the Identity of Both Organisms

The critical issue is not the "intermediate" susceptibility designation itself, but rather which organism shows intermediate susceptibility:

  • If the intermediate organism is E. coli, Klebsiella, Enterococcus, or Staphylococcus species: Continue nitrofurantoin. These organisms can still respond clinically even with intermediate MICs because nitrofurantoin achieves extremely high urinary concentrations (20-25% of the dose is excreted unchanged in urine) 3

  • If the intermediate organism is Proteus, Serratia, or Pseudomonas: Change antibiotics immediately. Nitrofurantoin has no activity against these organisms regardless of reported susceptibility 3

2. Understand "Intermediate" Susceptibility in the Urinary Context

Nitrofurantoin is unique among antibiotics because:

  • It achieves bactericidal concentrations only in urine, not in serum or tissues 3, 4
  • Plasma levels remain low (<1 mcg/mL), but urinary concentrations are dramatically higher 3
  • Standard MIC breakpoints may underestimate clinical efficacy for lower UTIs because they don't account for these exceptional urinary concentrations 4

Clinical implication: An organism with "intermediate" susceptibility may still be eradicated if the infection is limited to the bladder (uncomplicated cystitis), but would likely fail if there is tissue invasion (pyelonephritis, prostatitis, or complicated UTI).

3. Confirm This is Uncomplicated Cystitis

Nitrofurantoin should only be used for uncomplicated lower UTI 1, 2:

  • Continue nitrofurantoin if: Dysuria, frequency, urgency only; no fever, flank pain, or systemic symptoms
  • Change antibiotics if: Fever, flank pain, pyelonephritis, pregnancy, male patient, catheter-associated infection, or renal insufficiency (CrCl <30 mL/min) 1, 5

4. Polymicrobial Infections: A Red Flag

Two organisms in urine culture warrant consideration of:

  • Contamination: Was this a clean-catch midstream specimen? If collection technique was suboptimal, repeat the culture
  • Complicated UTI: Polymicrobial infections suggest structural abnormalities, stones, or catheter-associated infection 1
  • True polymicrobial cystitis: Rare in uncomplicated cystitis but can occur

If both organisms are typical uropathogens (e.g., E. coli + Enterococcus) and this is truly uncomplicated cystitis, nitrofurantoin provides coverage for both, as it has broad activity against common Gram-negative and Gram-positive uropathogens 3, 4

When to Change Antibiotics

Switch to an alternative agent if:

  1. Intrinsically resistant organism identified (Proteus, Serratia, Pseudomonas) 3
  2. Upper tract involvement (pyelonephritis) - nitrofurantoin does not achieve adequate tissue concentrations 1, 2
  3. Complicated UTI (catheter, stones, anatomic abnormalities) 1
  4. Severe renal insufficiency (CrCl <30 mL/min) 5
  5. No clinical improvement after 48-72 hours of therapy 1

Alternative Agents if Change is Needed

Based on guidelines 1, 2:

  • For uncomplicated cystitis: Fosfomycin 3g single dose, or TMP-SMX if local resistance <20%
  • For pyelonephritis or complicated UTI: Ceftriaxone, fluoroquinolone, or TMP-SMX based on susceptibilities and local resistance patterns

Common Pitfalls to Avoid

  • Don't assume "intermediate" means treatment failure: Nitrofurantoin's unique pharmacokinetics make urinary concentrations far exceed standard MIC breakpoints 3, 4
  • Don't use nitrofurantoin for pyelonephritis: Low tissue penetration makes it ineffective for upper tract infections 1, 2
  • Don't ignore intrinsic resistance: Proteus and Pseudomonas will not respond regardless of reported susceptibility 3
  • Don't increase the dose: Standard dosing (100 mg BID) already achieves maximal urinary concentrations; higher doses only increase toxicity risk without improving efficacy 3

References

5
Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Related Questions

For a patient with confusion, increased urination, and cloudy urine, should I start nitrofurantoin (Macrobid) or first obtain a urinalysis and urine culture?
A patient who took nitrofurantoin (Macrobid) three weeks ago now has a positive urine dipstick indicating a urinary tract infection; what should I order?
Can nitrofurantoin be used in a pregnant woman?
In an 83‑year‑old patient with urinary‑tract infection symptoms and a urine culture showing no bacteria and only few white cells, should nitrofurantoin (Macrobid) be discontinued and what alternative management is recommended, considering renal function?
In a 54-year-old female with recurrent suprapubic pain after completing nitrofurantoin, a normal urine dipstick, and no urinary symptoms, what is the appropriate next step in management?
How long is postoperative incisional pain expected after a laparoscopic appendectomy?
What is the TP segment on an electrocardiogram (ECG) and how should elevations or depressions be evaluated and managed?
Can I apply buddy taping to a finger before obtaining radiographs when X‑ray imaging is not available in the clinic?
In an active adult with lateral knee (patellar‑tendon) tendinopathy, are sodium (hyaluronic‑acid) injections more effective than cortisone (corticosteroid) injections?
What is methocarbamol, and what are its adult dosing regimen, contraindications, and common adverse effects for acute painful musculoskeletal conditions?
Is a non‑fasting urine volume of 2,300 mL considered diabetes insipidus (DI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.